These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37738858)

  • 1. The role of interferon in the thymus.
    Martinez RJ; Hogquist KA
    Curr Opin Immunol; 2023 Oct; 84():102389. PubMed ID: 37738858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility.
    Hale BG
    Eur J Immunol; 2023 Jun; 53(6):e2250164. PubMed ID: 37027328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and III interferons are good markers to monitor COVID-19 pathophysiology.
    Darif D; Ejghal R; Desterke C; Outlioua A; Hammi I; Lemrani M; Hilali F; Guessous F; Zaid Y; Akarid K
    Cytokine; 2023 May; 165():156172. PubMed ID: 36924609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.
    Casanova JL; Anderson MS
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective versus Pathogenic Type I Interferon Responses during Virus Infections.
    Jung KI; McKenna S; Vijayamahantesh V; He Y; Hahm B
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells.
    Doldan P; Dai J; Metz-Zumaran C; Patton JT; Stanifer ML; Boulant S
    J Virol; 2022 Sep; 96(17):e0070622. PubMed ID: 36000839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
    Quarleri J; Delpino MV
    Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection-induced inflammation from specific inborn errors of immunity to COVID-19.
    Ku CL; Chen IT; Lai MZ
    FEBS J; 2021 Sep; 288(17):5021-5041. PubMed ID: 33971084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes.
    Feng E; Balint E; Poznanski SM; Ashkar AA; Loeb M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon autoantibodies as signals of a sick thymus.
    Oftedal BE; Sjøgren T; Wolff ASB
    Front Immunol; 2024; 15():1327784. PubMed ID: 38455040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
    J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
    Sacchi A; Giannessi F; Sabatini A; Percario ZA; Affabris E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of type-I and type-III interferons in gastrointestinal homeostasis and pathogenesis.
    Wright AP; Nice TJ
    Curr Opin Immunol; 2024 Feb; 86():102412. PubMed ID: 38518661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis.
    Wang X; Tang Q; Li H; Jiang H; Xu J; Bergquist R; Qin Z
    Int J Infect Dis; 2023 May; 130():147-152. PubMed ID: 36907547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.